Lv1
38 积分 2024-01-16 加入
Rituximab improves SLE disease activity
1个月前
已完结
Efficacy and safety of obinutuzumab on progressive IgA nephropathy: a case series
2个月前
已完结
Obinutuzumab May Be an Effective and Safe Option for Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis Patients after Multitarget Therapy Including Rituximab
2个月前
已完结
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2个月前
已完结
Study of the dynamic changes in the non-volatile chemical constituents of black tea during fermentation processing by a non-targeted metabolomics approach
2个月前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
2个月前
已完结
Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India
2个月前
已完结
Incidence and prevalence of systemic lupus erythematosus in urban China, 2013–2017: A nationwide population-based study
2个月前
已完结
Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study
2个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
皖公网安备34019202002308
